Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma

<table>CT scan of the abdomen showing a 3.6 × 2.4 cm cystic lesion within the uncinate process of the pancreas extending into the pancreatic head.</table>

Case Reports in Endocrinology

fig2

Figure 2

Figure 2: Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma 

Figure 2 | Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma 